MODERN BIOSCIENCES LIMITED

N1C 4AG (London)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£1,562,595

Dec 12 - May 15

Novel, oral anti-inflammatory compounds for the treatment of rheumatoid arthritis

Innovate UK award to MODERN BIOSCIENCES LIMITED and Lisa Patel

£2,400,000

Mar 15 - Feb 18

Novel, oral bone-protecting compounds for the treatment of rheumatoid arthritis

Innovate UK award to MODERN BIOSCIENCES LIMITED and Lisa Patel

£2,748,857

May 21 - Oct 24

Demonstrating proof of concept of a first-in-class metabolic reprogramming agent that aims to promote myelin regeneration and anti-inflammatory effects in patients with Multiple Sclerosis

Innovate UK award to MODERN BIOSCIENCES LIMITED and Chris Hill

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}